MoneyWorks4Me

Zydus Lifesciences informs about receipt of demand order-in-original

20 Aug 2024 Evaluate
Zydus Lifesciences has informed that Zydus Healthcare, a wholly owned subsidiary (ZHL) has received a Demand Order-In-Original (O-I-O) for the financial year 2019-20 from Commercial Tax Officer, Ward-8, Chandigarh, on the issue pertaining to Input Tax Credit (ITC). The details as required under regulation 30 of Listing Regulations read with SEBI Circular are enclosed.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1746.00
Dr. Reddys Labs. 1235.40
Cipla 1328.70
Lupin 1952.30
Zydus Lifesciences 1122.40
View more..